Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Terrassa
Clinical trial register · Spain

Clinical Trials in Terrassa, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Consorci Sanitari de Terrassa12 Hospital Mutua de Terrassa7 Regeneron Pharmaceuticals5 Pfizer4 Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa3
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Terrassa

79 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
PETHEMA Foundation
Phase 3
376
Santiago de Compostela, Hospitalet Del Llobregat, Terrassa, Jaén, Alcalá de Henares, San Sebastián de los Reyes, Málaga, Barakaldo
2026-07-02
Not yet open
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Observational
1,300
Barcelona, Terrassa
2026-04-10
Recruiting
Consorci Sanitari de Terrassa
Not applicable
230
Terrassa
2026-03-31
Recruiting
Bristol-Myers Squibb
Phase 3
650
Getxo, Elche (alicante), Madrid, Málaga, Pamplona, Salamanca, Seville, Terrassa
2025-12-02
Not yet open
CGM Accuracy in Pregnancy Study
NCT07269015Pregestational Diabetes, Continuous Glucose Monitoring
Hospital Mutua de Terrassa
Not applicable
66
Terrassa
2025-12
By invitation
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
NCT07287163Epilepsy, Tonic-Clonic, Focal Seizure, Primary Generalized Seizure
Praxis Precision Medicines
Phase 3
700
Barcelona, Madrid, Málaga, Terrassa, Valencia
2025-10-27
Recruiting
Jamil Cedeño Mora
Observational
1,200
Terrassa, Getafe, Madrid, Majadahonda, Móstoles, Valencia, Zaragoza
2025-10-01
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Sant Cugat del Vallès, Terrassa, Donostia / San Sebastian, Lleida, Pozuelo de Alarcón, Barcelona, Córdoba, Madrid
2025-09-17
Recruiting
Merz Therapeutics GmbH
Phase 3
990
Barcelona, Madrid, Málaga, Seville, Terrassa, Valencia, Vigo, Zaragoza
2025-08-21
Recruiting
Merz Therapeutics GmbH
Phase 3
780
Barcelona, Madrid, Málaga, Seville, Terrassa, Valencia, Vigo, Zaragoza
2025-08-21
Recruiting
Merck Sharp & Dohme LLC
Phase 2
340
Terrassa, Barcelona
2025-07-16
Recruiting
Bristol-Myers Squibb
Phase 3
426
Getxo, Elche (alicante), Madrid, Málaga, Pamplona, Salamanca, Seville, Terrassa
2025-07-10
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Denia, Martorell, Terrassa, Pozuelo de Alarcón, Barcelona, Córdoba, Donosti-San Sebastián, Granada
2025-07-02
Recruiting
Chronic Insomnia in Non-Cancer Pain Patients
NCT07057232Chronic Non-cancer Pain, Insomnia
Germans Trias i Pujol Hospital
Observational
385
Badalona, Barcelona, Girona, Hospitalet Del Llobregat, Lleida, Sant Joan Despí, Tarragona, Terrassa
2025-06-09
Recruiting
Hospital Mutua de Terrassa
Observational
1,000
Terrassa
2025-06-01
By invitation
Prevalence of Sarcopenia in Patients Admitted to ICU and Its Progression During Hospitalization.
NCT07303335Sarcopenia, Critical Illness, Intensive Care (ICU) Myopathy, Body Composition Measurement
Hospital Mutua de Terrassa
Observational
100
Terrassa
2025-05-14
Active, closed
Consorci Sanitari de Terrassa
Not applicable
80
Barcelona, Terrassa
2025-05-05
Recruiting
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Observational
153
Vitoria-Gasteiz, Badalona, L'Hospitalet de Llobregat, Manresa, Mataró, Terrassa, Viladecans, Torrelavega
2025-04-14
Active, closed
Consorci Sanitari de Terrassa
Not applicable
104
Terrassa
2025-04-07
Recruiting
Consorci Sanitari de Terrassa
Not applicable
84
Terrassa
2025-03-01
Not yet open
Hospital Mutua de Terrassa
Not applicable
148
Terrassa
2025-01
Active, closed
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Phase 2
28
Palma de Mallorca, Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Lleida, Tarragona, Terrassa
2024-12-16
Recruiting
Regeneron Pharmaceuticals
Phase 3
975
Córdoba, L'Hospitalet de Llobregat, Terrassa, Burjassot, Barcelona, Seville, Valencia, Zaragoza
2024-10-30
Recruiting
RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
NCT06919341ITP - Immune Thrombocytopenia, Primary Immune Thrombocytopenia (ITP)
Fundación Española de Hematología y Hemoterapía
Observational
1,000
A Coruña, Palma, Barcelona, Terrassa, Bilbao, Torrelavega, Castellon, Algeciras
2024-09-27
Recruiting
Regeneron Pharmaceuticals
Phase 2
116
Granada, Terrassa, El Palmar, Gijón, Barcelona, Madrid, Murcia
2024-09-16
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 2
55
Barcelona, Getxo, Lleida, Madrid, Pamplona, Pozuelo de Alarcón, Sant Cugat del Vallès, Terrassa
2024-07-22
Recruiting
Vor Biopharma
Phase 3
180
Alicante, Barcelona, Terrassa, Bilbao, Valencia
2024-07-17
Recruiting
Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment
NCT06404931Prolapse; Female, Prolapse Genital, Prolapse Uterovaginal
Hospital Mutua de Terrassa
Phase 2
90
Terrassa
2024-07-01
Recruiting
Immunological Characteristics of Preclinical IBD
NCT05698745Crohn Disease, Ulcerative Colitis, IBD
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Observational
450
Santiago de Compostela, Badalona, Manresa, Terrassa, Donostia / San Sebastian, Vigo, Gijón, Oviedo
2024-06-01
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Badalona, Barcelona, Terrassa, San Sebastián, Madrid, Majadahonda, Seville, A Coruña
2024-05-20
Recruiting
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Phase 2
51
Zaragoza, Barcelona, L'Hospitalet de Llobregat, Bilbao, Salamanca, Valladolid, Terrassa, Santiago de Compostela
2024-05-16
Recruiting
Pfizer
Phase 3
492
Badalona, Terrassa, Barakaldo, Barcelona, Murcia, Girona, Valencia, Madrid
2024-02-08
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Santiago de Compostela, Seville, Palma, Badalona, Sabadell, Terrassa, Santander, A Coruña
2023-12-13
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Seville, Sabadell, Terrassa, Barakaldo, Majadahonda, Pozuelo de Alarcón, Pamplona, Oviedo
2023-11-14
Active, closed
AbbVie
Observational
146
Vitoria-Gasteiz, Manresa, Terrassa, Jerez de la Frontera, Laredo, Santander, Las Palmas de Gran Canaria, León
2023-11-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Badalona, Terrassa, Galdakao-Usansolo, Fuenlabrada, Madrid, Torrejón de Ardoz, Valencia
2023-10-25
Active, closed
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
NCT05952037Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory
DrugsSonrotoclax·Zanubrutinib
BeOne Medicines
Phase 2
114
Barcelona, Madrid, Salamanca, Seville, Terrassa
2023-10-23
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
Santiago de Compostela, Vitoria-Gasteiz, Palma, Palma Mallorca, Badalona, Terrassa, Santander, León
2023-09-18
Recruiting
Biotest
Phase 3
590
Palma de Mallorca, Sabadell, Terrassa, Córdoba, Majadahonda, Pamplona, Oviedo, Barcelona
2023-09-09
Active, closed
nthalmic Pty Ltd
Not applicable
441
Terrassa, Santiago de Compostela, Madrid
2023-08-04
Active, closed
Eagle Pharmaceuticals, Inc.
Phase 2
276
Barcelona, Madrid, Santiago de Compostela, Tarragona, Terrassa, Toledo, Valencia, Valladolid
2023-07-22
Active, closed
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT05696717Symptomatic Neurogenic Orthostatic Hypotension, MSA - Multiple System Atrophy
Theravance Biopharma
Phase 3
102
Terrassa, Barakaldo, Madrid
2023-06-27
Active, closed
Consorci Sanitari de Terrassa
Not applicable
140
Terrassa
2023-06-06
Active, closed
Grupo Espanol Multidisciplinario del Cancer Digestivo
Observational
120
Badalona, Terrassa, Madrid, Barcelona, Girona, Valencia, Zaragoza
2023-05-26
Recruiting
Hospital Mutua de Terrassa
Observational
500
Terrassa
2023-05-01
Recruiting
Consorci Sanitari de Terrassa
Not applicable
60
Terrassa
2023-05-01
Active, closed
Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial)
NCT05817604Kidney Neoplasm, Renal Cancer, Inoperable Disease, SBRT
Consorci Sanitari de Terrassa
Observational
60
Terrassa
2023-03-01
Recruiting
Consorci Sanitari de Terrassa
Not applicable
98
Terrassa
2023-02-20
Recruiting
Instituto de Investigación Hospital Universitario La Paz
Observational
150
Terrassa, Lugo, Madrid, Barcelona
2023-01-02
Recruiting
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Not applicable
40
Badalona, L'Hospitalet de Llobregat, Manresa, Sabadell, Sant Joan Despí, Terrassa, Cáceres, Girona
2022-11-29
Recruiting
Pfizer
Phase 3
1,060
Santiago de Compostela, Badalona, L'Hospitalet Del Llobregat, Terrassa, Santander, Barcelona, Girona, Madrid
2022-11-10
Recruiting
Fundacion Clinic per a la Recerca Biomédica
Phase 4
360
Alicante, Seville, Palma de Mallorca, Barcelona, Sabadell, Terrassa, Barakaldo, Santander
2022-08-17
Recruiting
Endoscopic Ultrasound-Guided Gastroenterostomy Nationwide: Prospective Registry.
NCT05128604Endoscopic Surgical Procedure, Safety, Training
Hospital Universitari de Bellvitge
Observational
50
Badalona, L'Hospitalet de Llobregat, Terrassa, Barcelona, Girona
2022-05-23
Active, closed
Pfizer
Phase 3
854
Santiago de Compostela, Barcelona, L'Hospitalet Del Llobregat, Terrassa, Badalona, Salamanca, Pozuelo de Alarcón, Madrid
2022-03-25
By invitation
UCB Biopharma SRL
Phase 3
300
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Seville, Terrassa, Valencia, Valladolid
2022-02-03
Recruiting
Hospital Mutua de Terrassa
Observational
80
Terrassa
2022-01-01
Recruiting
UCB Biopharma SRL
Phase 3
350
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Seville, Terrassa, Valencia, Valladolid
2021-12-07
Recruiting
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
NCT04743765Hip Fractures, Myocardial Injury
Population Health Research Institute
Not applicable
1,100
Barcelona, Sabadell, Sant Pere de Ribes, Terrassa, Marbella, Valladolid, Madrid
2021-11-22
Active, closed
AbbVie
Observational
873
Badalona, Barcelona, L'Hospitalet de Llobregat, Terrassa, Granada, Huelva, Jaén, Logroño
2021-11-17
Recruiting
Pfizer
Phase 3
893
Santiago de Compostela, L'Hospitalet Del Llobregat, Terrassa, Santander, Pamplona, Toledo, Barcelona, Girona
2021-10-04
Recruiting
EDUARDO ALBENIZ
Observational
1,200
Palma de Mallorca, Porto Cristo, Granollers, Terrassa, Aranda de Duero, Mérida, Ourense, Majadahonda
2021-09-09
Recruiting
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
NCT04889924Breast Cancer, Chemotherapy, Sentinel Lymph Node, Axillary Lymph Nodes Dissection
Hospital Universitari de Bellvitge
Not applicable
820
Badalona, Calella, Granollers, L'Hospitalet de Llobregat, Manresa, Mataró, Sant Cugat del Vallès, Terrassa
2021-06-11
Active, closed
Rectal Tumor Resection Using the UNI-VEC Multichannel Transanal Access Device
NCT06286956Rectal Polyp, Rectal Polyps, Rectal Lesion, Sessile Colonic Polyp
Vecmedical Spain, S.L.
Not applicable
40
Barcelona, Terrassa, A Coruña, Lugo, Vigo, Madrid, Murcia, Gijón
2021-04-19
Active, closed
Integrated Patient Care Intradialysis Programme in Hemodialysis Through a Virtual Health Platform
NCT04823286End Stage Renal Disease, Hemodialysis-Induced Symptom, Chronic Kidney Diseases
Cardenal Herrera University
Not applicable
70
Terrassa, Manises, Valencia
2021-03-31
Recruiting
Integrative Diagnosis for SCD and Other RADs
NCT07206095Sickle Cell Disease, Thalassaemia, Congenital Dyserythropoietic Anemia (CDA), Enzyme Disorder; Anemia
Hospital Universitari Vall d'Hebron Research Institute
Observational
200
Barcelona, Esplugues de Llobregat, Granollers, Mataró, Sabadell, Terrassa, Lleida
2020-11-13
Recruiting
Consorci Sanitari de Terrassa
Observational
140,660
Terrassa
2020-03-01
Recruiting
Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
NCT04367883COVID19, Influenza Vaccination, ACE Inhibitors, ARB
DrugsACEI·Amantadine
Consorci Sanitari de Terrassa
Observational
3,000
Terrassa
2020-03-01
Active, closed
Registry Study of Pregnancy and Breast Cancer
NCT04603820Breast Cancer and Pregnancy
Spanish Breast Cancer Research Group
Observational
866
Palma de Mallorca, Badalona, Terrassa, Bilbao, Santa Cruz de Tenerife, A Coruña, Las Palmas de Gran Canaria, Leganés
2019-11-18
Active, closed
Inotrem
Phase 2
355
Barcelona, Madrid, Oviedo, Terrassa, Valencia
2019-11-13
Active, closed
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
DrugXeomin
Merz Pharmaceuticals GmbH
Phase 3
603
Huelva, Madrid, Terrassa
2019-09-16
Recruiting
Spine Bone Cements Outcomes - Post Market Follow-up
NCT06367582Vertebral Fracture, Compression Fracture, Osteoporotic Fractures
Teknimed
Observational
500
Barcelona, Granada, Murcia, Terrassa, Zafra
2019-09-04
Active, closed
Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy
NCT04262609Faecal Incontinence, Prostate Cancer
Consorci Sanitari de Terrassa
Observational
200
Terrassa
2019-07-01
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Badalona, Barcelona, Cartagena, Córdoba, Madrid, Pamplona, Salamanca, Terrassa
2019-06-24
Active, closed
Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR
NCT03767621Coronary Artery Disease, Left Main Coronary Artery Stenosis, Left Main Coronary Artery Disease, Restenosis, Coronary
Fundación EPIC
Observational
300
Terrassa, Cartagena, El Palmar, Castellon, Galdakao, Albacete, Badajoz, Badalona
2019-02-19
Recruiting
Consorci Sanitari de Terrassa
Observational
50
Terrassa
2016-10-01
Recruiting
Spanish Breast Cancer Research Group
Observational
1,867
Elche, Manresa, Terrassa, San Sebastián, Las Palmas de Gran Canaria, Alcorcón, Fuenlabrada, Leganés
2016-08
Active, closed
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2
50
Barcelona, Terrassa, Burgos, Alcorcón, Madrid, Cartagena, Marbella, Seville
2016-05-18
Active, closed
LEGION Hinge Safety and Efficacy Study
NCT02445443Knee Arthroplasty, Total
Smith & Nephew, Inc.
Observational
47
Terrassa
2015-06-30
Active, closed
A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee
NCT01542580Osteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis, Post Traumatic Deformity
Zimmer Biomet
Observational
255
Terrassa
2012-03
Rows per page Showing 1–79 of 79
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/terrassa

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 79 of those studies with a site in Terrassa.

How many clinical trials are recruiting in Terrassa?

46 of the 79 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 27 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Terrassa), 79 studies
PhaseStudiesRecruitingShare
Observational291836.7%
Phase 3241630.4%
Not applicable15719%
Phase 210412.7%
Phase 4111.3%

Most active sponsors

Lead sponsors with the most studies (Terrassa)
Lead sponsorStudiesRecruiting
Consorci Sanitari de Terrassa127
Hospital Mutua de Terrassa74
Regeneron Pharmaceuticals54
Pfizer43
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa33
AbbVie20
Bristol-Myers Squibb22
Hoffmann-La Roche21
Hospital Universitari de Bellvitge22
Merck Sharp & Dohme LLC21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.